Technology Services
For more information on PPD's Phase II-IIIb clinical technology services, please choose an option from the drop-down box below.
To expedite drug development, PPD continues to develop, acquire and implement advancements in clinical trial software and other technologies to enhance capabilities, increase efficiencies, expand capacity and generate quality data outcomes.
PPD technical personnel are knowledgeable of the drug development process and clinical trial software environment. That expertise enables technology to be applied and effectively utilized to augment proven business processes.
With more than 400 technical personnel worldwide, we are able to support in-house requirements while providing clients consulting expertise on clinical trial software and other technical needs throughout the drug development process. This expertise has proven invaluable to clients when study requirements change or new needs develop.
We continually research new technologies, including clinical trial software, that have the capacity to streamline processes and expedite drug development. Our current technology offering includes the following:
Data integrity and security are unwavering principles that PPD incorporates into all technology decisions and investments. As part of a highly regulated industry, we understand the value and need for data accuracy and invest in systems and processes to ensure maximum security.
Electronic Data Capture (EDC) | Clinical Trial Electronic Submissions |
IVR and IWR Systems | IVR and IWR System Services |
Adverse Event Adjudication | PPD® 3D-Virtual Environment |
Clinical Trial Software Consulting | Clinical Trial Software Products |
Clinical Trial Safety Reporting | Client Portals - PPD DirectConnect™ |